The Cigna Group CI

Revenue Intelligence Report • 32 quarters of SEC filing data • Updated 2026-03-15

Our econometric model shows the 9.1% YoY revenue drop is being offset more by SG&A efficiency than by member growth or pricing power—SG&A ROI of 22.77x implies growth is coming from how effectively overhead and marketing are monetized, not just volume. The holdout miss (predicted 67.8B vs actual 72.5B, -6.5%) signals forecast sensitivity and out-of-sample risk, even as overall MAPE sits at 5.8%. Near-term upside hinges on sustaining SG&A-driven lift and favorable mix rather than a new product cycle. In a competitive, highly regulated market, the path to margin resilience depends on enrollment stability, pricing discipline, and ongoing efficiency gains.

Investment Thesis

The econometric model achieves strong accuracy (5.8% MAPE), suggesting The Cigna Group's revenue trajectory is well-characterized by its spending patterns. Each $1 of SG&A spending generates $22.77 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$249.8B
-9.1% YoY
SG&A Multiplier
$22.77 per $1
Model Accuracy
5.8% MAPE
Holdout validation: The model predicted $68B vs the actual $72B — an error of 6.5%.
Note: The Cigna Group does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

CI Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $68B $72B $60B – $76B +3.3% ✓ In range
Q2 2026 $65B $54B – $76B -0.7%
Q3 2026 $63B $50B – $77B -6.1%
Q4 2026 $62B $46B – $77B -11.7%
Q1 2027 $60B $43B – $77B -17.2%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture The Cigna Group's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 0.9703 -3.0% In line with trend 7
FQ2 (Dec–Feb) 0.9913 -0.9% In line with trend 7
FQ3 (Mar–May) 0.9749 -2.5% In line with trend 7
FQ4 (Jun–Aug) 0.9996 -0.0% In line with trend 7

How Spending Drives Revenue

CI Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

JNJ COO TECH DXCM VRTX BSX HSIC STE